Logo image
Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction
Journal article   Open access   Peer reviewed

Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction

C. A GUNNETT, D. D LUND, A. K MCDOWELL, F. M FARACI and D. D GHEISTAD
Arteriosclerosis, thrombosis, and vascular biology, Vol.25(8), pp.1617-1622
2005
DOI: 10.1161/01.ATV.0000172626.00296.ba
PMID: 15933248
url
https://doi.org/10.1161/01.ATV.0000172626.00296.baView
Published (Version of record) Open Access

Abstract

Objective— Inducible nitric oxide synthase (iNOS) is expressed in arteries during inflammation and may contribute to vascular dysfunction. Effects of gene transfer of iNOS to carotid arteries were examined in vitro in the absence of systemic inflammation to allow examination of mechanisms by which iNOS impairs contraction and relaxation. Methods and Results— After gene transfer of iNOS with an adenovirus (AdiNOS), constrictor responses to phenylephrine (PE) and U46619 were impaired. After AdiNOS, inhibition of soluble guanylate cyclase (sGC) with 1H-[1,2,4]oxadiazolo-[4,3,2]quinoxalin-1-one (ODQ) reduced the EC50 for PE from 4.33±0.78 μmol/L to 1.15±0.43 μmol/L (mean±SEM). These results imply that iNOS impairs contraction by activation of the NO/cGMP pathway. Relaxation to acetylcholine (ACh) also was impaired after AdiNOS. Sepiapterin (300 μmol/L), the precursor for tetrahydrobiopterin (BH4), improved relaxation to Ach. Because BH4 is an essential cofactor for production of NO by both iNOS and endothelial nitric oxide synthase (eNOS), these results suggest that iNOS may reduce production of NO by eNOS by limiting availability of BH4. Next, we examined effects of expression of iNOS in endothelium and adventitia. Selective expression of iNOS in endothelium, but not adventitia, impaired contraction to phenylephrine and relaxation to acetylcholine. Conclusions— We conclude that: (1) iNOS may impair contraction in part by activation of sGC; (2) iNOS impairs relaxation, at least in part, by limiting availability of BH4; and (3) expression of iNOS in endothelium may be a more important mediator of vascular dysfunction than expression of iNOS in adventitia.
Heart Cardiology. Vascular system Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Atherosclerosis (general aspects, experimental research) Biological and medical sciences Medical sciences Coronary heart disease Blood and lymphatic vessels

Details

Metrics

Logo image